Royal Philips has announced the launch of the InnoSpire Go hand-held vibrating mesh nebulizer system in the US. InnoSpire Go is already available in the UK, Australia, Denmark, Finland, Germany, and Norway. Philips acquired the vibrating mesh nebulizer technology from Aerogen in 2014. According to the company, InnoSpire Go delivers 2.5 ml of albuterol … [Read more...] about Philips launches InnoSpire Go nebulizer in US
Products and Services
Lindal launches Cyrano nasal actuator
Lindal Group has launched a new nasal actuator called Cyrano, which has a rounded asymmetric pyramidal shape. According to the company, the actuator shape preventing insertion of the device too far into the nose, and Cyrano is intended for use across the infant, pediatric, and adult markets. The actuator also is designed to prevent liquid from being retained in the … [Read more...] about Lindal launches Cyrano nasal actuator
Iconovo partners with McMaster University to develop inhaled TB vaccine
Dry powder inhaler developer Iconovo has announced a partnership with McMaster University for development of a dry powder tuberculosis vaccine to be delivered via Iconovo's ICOone single-dose DPI. According to the company, the ICOone inhaler will "will be used as a test platform to facilitate future commercialization and large-scale manufacturing." The 3-year … [Read more...] about Iconovo partners with McMaster University to develop inhaled TB vaccine
Proveris Scientific certified to ISO 9001:2015 quality standard
Proveris Scientific, which offers a variety of products and services related to aerosol characterization, has achieved certification to the ISO 9001:2015 quality standard through October 2021, the company said. TUV Rheinland of North America, which is accredited through the ANSI-ASQ National Accreditation Board (ANAB), verified the company's conformance to the … [Read more...] about Proveris Scientific certified to ISO 9001:2015 quality standard
KAER Biotherapeutics gets $2 million grant from NIH for aerosol delivery of surfactant for ARDS
KAER Biotherapeutics has been awarded a $2 million Phase 2 Small Business Innovation Research (SBIR) grant by the National Heart Lung and Blood Institute of the National Institutes of Health for development of a device based on its SUPRAER aerosol technology for delivery of surfactant to treat acute respiratory distress syndrome (ARDS), the company said. In 2015, … [Read more...] about KAER Biotherapeutics gets $2 million grant from NIH for aerosol delivery of surfactant for ARDS
Experic hires OINDP specialist, announces plans for new facility and DPI services
US-based pharmaceutical supply services firm Experic is expanding its focus with the appointment of DPI expert Justin Lacombe as Director of Pharmaceutical Development and Manufacturing Services and the announcement that the company has leased a new facility that will offer development and manufacturing services for a variety of dosage forms, including dry powder … [Read more...] about Experic hires OINDP specialist, announces plans for new facility and DPI services
Micro-Sphere adds DPI capsule filling capacity
Swiss CDMO Micro-Sphere has announced the addition of new DPI capsule filling capacity with a new MG2 Tekna filling machine in a dedicated, humidity-controlled cleanroom at its facility near Lugano. The company also has added a MultiNETT 100% weight control system. Earlier this year, the company announced that the facility, which was recently expanded, had … [Read more...] about Micro-Sphere adds DPI capsule filling capacity
Aptar Pharma announces launch of PureHale device
Aptar Pharma has announced that it will officially launch its new PureHale aerosol device at CPhI Worldwide. Purehale, a bag-on-valve "nebulizer-like device," is a finalist for the CPhI Pharma Awards in the drug delivery device category. Although the blurb for PureHale on the CPhI page says, "Delivering portable respiratory relief, revolutionizing the nebulizer … [Read more...] about Aptar Pharma announces launch of PureHale device
Merxin signs deal for development of tiotropium/olodaterol product using its MRX004 SMI
Device developer Merxin has announced that a European generics company has acquired exclusive worldwide rights for development of a tiotropium/olodaterol product for the treatment of COPD using Merxin's MRX004 softmist inhaler. Boehringer Ingelheim markets its tiotropium/olodaterol soft mist inhaler as Stiolto Respimat in the US and Spiolto Respimat in … [Read more...] about Merxin signs deal for development of tiotropium/olodaterol product using its MRX004 SMI
Catalent completes acquisition of Juniper Pharma Services
Catalent will continue to offer DPI development and manufacturing services at the Nottingham, UK Juniper Pharma Services facility that was part of its recently completed acquisition of Juniper Pharmaceuticals, the company says. Catalent announced its intent to acquire Juniper in July 2018. The Nottingham facility was originally owned by Molecular Profiles, which … [Read more...] about Catalent completes acquisition of Juniper Pharma Services